Efficient Funding of Chemotherapy Review

Page last updated: 1 May 2021

The Department of Health is conducting a review of the Efficient Funding of Chemotherapy (EFC) under the Pharmaceutical Benefits Scheme. The EFC review will seek to investigate current processes involved in the production, distribution of and access to chemotherapy medicines provided by the EFC supply chain to identify whether arrangements may be amenable to simplification to improve efficiency and equitable access in the long term.

Further information including Terms of Reference, Discussion Paper link, information and announcements to follow.

Terms of Reference – Review of the Efficient Funding of Chemotherapy (PDF 586KB) - (Word 20KB)